Primer: Yunnan Baiyao Group Co., (000538 CH) - Sep 2025
Strong Brand Equity and Market Leadership: Yunnan Baiyao is a household name in China with a dominant position in the Traditional Chinese...
120 Views
Pre-IPO Mandi Inc. - The Business Model, the Concerns and the Valuation
​Mandi's short-term success hinges on Minoxidil, but uncertainty looms with Winlevi and semaglutide. Growth may slow due to VBP and competition. A...
220 Views
Jiangsu Hengrui Pharma H Share Listing: The Investment Case
Hengrui Pharma has filed its PHIP for an H Share listing to raise US$2 billion. In this note, we discuss the key tenets of the investment case.
538 Views
DeekSeek May Not Be The "Game Changer" In China Healthcare - Time to Be Rational
​DeepSeek's integration with companies brings market optimism, but risks remain due to unsustainable profit model and data security...
323 Views
DeepSeek Ignites China Healthcare - The Investment Opportunities and Risks Behind
DeepSeek is revolutionizing the healthcare industry, but face data security issue and US restriction on cooperation with China.Companies...
609 Views